Several non-insulin-based therapies are available for the management of T2D, including metformin, sulfonylureas, thiazolidinediones, dipeptidyl peptidase 4 inhibitors (DPP-4i), sodium-glucose co-transport-2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1RA), amylin analogues, and alpha-glucosidase inhibitors
When a medication comes off patent, cheaper generics/biosimilars tend to come to market
Ipamorelin, on the other hand, is well-tolerated by most individuals and has a much lower risk of side effects
Clarkson has not disclosed the type of drug she is taking, so it is not known if she is taking metformin or a different type of medication
First, it bypasses the stratum corneum directly
Thank you Megan